MARY JO HANIGAN: Open Payments
NPI 1306906326 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$16,801 in 211 payments from 22 companies in 2025. Trend: 2023 $20,880 · 2024 $29,868 · 2025 $16,801
Speaker / faculty: $13,091Food & beverage: $3,380Travel & lodging: $186Education: $145
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 26 | $13,589 |
| Axsome Therapeutics, Inc. | 18 | $523 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 26 | $394 |
| ABBVIE INC. | 31 | $373 |
| Vanda Pharmaceuticals Inc. | 12 | $274 |
| Alkermes, Inc. | 20 | $262 |
| Teva Pharmaceuticals USA, Inc. | 9 | $229 |
| E.R. Squibb & Sons, L.L.C. | 11 | $198 |
| HARMONY BIOSCIENCES LLC | 14 | $188 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $146 |
Products named: REXULTI, Auvelity, CAPLYTA, VRAYLAR, ARISTADA, COBENFY, WAKIX, FANAPT.
Industry payments across NE — which companies pay providers there.
